A Phase I/II Clinical Trial of Nivolumab and Plinabulin for Patients With Advanced Stage Non-small Cell Lung Cancer That Have Progressed Through First Line Platinum Doublet Chemotherapy
Phase of Trial: Phase I/II
Latest Information Update: 06 Jun 2017
At a glance
- Drugs Nivolumab (Primary) ; Plinabulin (Primary)
- Indications Non-small cell lung cancer
- Focus Adverse reactions; Therapeutic Use
- 26 May 2017 Planned primary completion date changed from 1 Sep 2017 to 1 Mar 2018.
- 19 Jan 2017 Status changed from not yet recruiting to recruiting.
- 15 Dec 2016 Planned initiation date changed from 1 Aug 2016 to 1 Feb 2017.